South Korea, which has 7.2% of its population vaccinated with at least one dose, uses the Pfizer/BioNTech vaccine on its frontline medical workers and the Oxford/AstraZeneca vaccine on the more numerous population in the long-term care arena:
By the end of March, authorities plan to complete injecting the first doses to some 344,000 residents and workers at long-term care settings, who will receive the Oxford-AstraZeneca vaccines, and 55,000 frontline medical workers, who will receive shots developed by Pfizer and BioNTech.
COVID-19 cases fell without the aid of vaccines in South Korea, and rose again despite them.
Since vaccination began on Feb 25, deaths per million stands today only where it was when the effort first began two and a half months ago.
 |
| vaccination |
 |
| cases |
 |
| deaths |
